Abstract
To assess the effectiveness of a multifaceted infection control strategy in limiting the nosocomial transmission of respiratory syncytial virus (RSV) infection to patients in a bone marrow transplant (BMT) unit. Before/after trial. University-affiliated tertiary cancer center. Adult BMT recipients hospitalized during two consecutive wintertime community outbreaks of RSV infection. An infection control strategy against nosocomial RSV infection was implemented in the BMT unit in February 1993. The strategy involved prompt identification, isolation, and cohorting of RSV-infected patients; prompt therapy with aerosolized ribavirin; use of masks and gloves by anyone entering an infected BMT patient's room; screening visitors for respiratory symptoms; restricting visitation by all children under 12 years of age and all family members and other visitors with RSV symptoms; and restricting symptomatic hospital staff from working in the BMT unit. After implementation of the multifaceted infection-control strategy, there were four cases of nosocomial RSV infection in 3,870 patient days (incidence density, 1.0 case/1,000 patient days) compared with 14 cases of nosocomial RSV infection in 3,152 patient days (incidence density, 4.4 cases/1,0...Continue Reading
Citations
Nov 28, 2001·International Journal of Hematology·M KamiY Mutou
Sep 13, 2012·Current Infectious Disease Reports·Defne Arslan, Lara Danziger-Isakov
Mar 17, 1997·The American Journal of Medicine·I RaadE Whimbey
Apr 27, 2000·Vaccine·L GoestchN Corvaïa
Aug 26, 1998·Vaccine·J E Crowe
Jul 26, 2003·Paediatric Respiratory Reviews·Alexandra Soldatou, E Graham Davies
Jul 18, 2002·Seminars in Pediatric Infectious Diseases·Jane D Siegel
Jul 20, 2002·Current Opinion in Infectious Diseases·Michael G Ison, Frederick G Hayden
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Christopher CianciMark Krystal
Jul 25, 2000·Clinical Microbiology Reviews·A R Falsey, E E Walsh
Dec 26, 2013·The Journal of Infectious Diseases·Per Ljungman
Dec 11, 2007·American Journal of Infection Control·Jane D SiegelUNKNOWN Health Care Infection Control Practices Advisory Committee
Nov 11, 2005·Antiviral Research·Joshua O OjwangCraig D Shimasaki
Nov 30, 1999·Hematology/oncology Clinics of North America·J A van Burik, D J Weisdorf
Aug 30, 2001·Critical Care Clinics·A Safdar, D Armstrong
Mar 13, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Helen Y ChuCorey Casper
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Dec 2, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Adriana F MachadoClarisse M Machado
May 27, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Benedetto BrunoMichael Boeckh
Dec 9, 2010·Blood·Jharna N Shah, Roy F Chemaly
Feb 24, 2016·Influenza and Other Respiratory Viruses·Clare E FrenchCharles R Beck
Mar 10, 2004·Chest·Jorge GarbinoLaurent Kaiser
Apr 13, 2010·Bone Marrow Transplantation·V LavergneC Béliveau
Aug 22, 2003·Clinical Journal of Oncology Nursing·Theresa Latchford, Brenda K Shelton
Nov 2, 2019·BMJ Open Quality·Carla CorpusJerome A Leis